Brazil getting closer to curbing AIDS

3 December 2007

The prevalence of HIV in Brazil dropped to 0.5% of the population last year from 0.6% in 2005, its first fall in seven years, stated Pedro Chequer, coordinator of the United Nations AIDS program in Brazil, reported by the Reuters news agency.

"There are first signs that the AIDS epidemic in Brazil could revert," he said after the release of an official report, which also showed the number of new AIDS cases registered in Brazil fell to 17.5 per 100,000 inhabitants in 2006 from 19.5 the year before and 22.2 in 2002.

"Our broad prevention policy is beginning to have a positive impact," commented Mariangela Simao, head of the government's AIDS program. "We are seeing a stabilization in the prevalence of AIDS," she said, but warning that rates needed to fall for several years before calling it a declining trend.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK







Today's issue

Company Spotlight